Patents Assigned to ProteoMedix AG
  • METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS
    Publication number: 20240337659
    Abstract: A method for collecting information about the health status of a subject involving the quantitative detection, in serum, plasma or blood of the subject, of the concentration of at least four of the systems selected from the group consisting of: THBS1, LUM, FN1, LG3BP, MMP9, as well as PSA.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 10, 2024
    Applicant: ProteoMedix AG
    Inventors: Ralph SCHIESS, Alcibiade ATHANASIOU, Ramy HUBER, Anja WITTIG
  • COMBINED METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND MPMRI DATA
    Publication number: 20240288433
    Abstract: Method for collecting information about the health status of a subject involving the quantitative detection, in serum, plasma or blood of the subject, of the concentration of THBS1, as well as the proportion of free PSA (% fPSA) in combination with data obtained from multi-parametric prostate magnetic resonance imaging data.
    Type: Application
    Filed: June 16, 2022
    Publication date: August 29, 2024
    Applicant: ProteoMedix AG
    Inventors: Ralph SCHIESS, Christian BRÜHLMANN, Oliver STRAUB, Alcibiade ATHANASIOU
  • Method of detecting proteins in human samples and uses of such methods
    Patent number: 11320435
    Abstract: A method for collecting information about the health status of a subject is proposed involving the quantitative detection, in serum, plasma or blood of the subject, of the concentration of THBS1, the proportion of free PSA (% fPSA), preferably including the concentration of at least one protein selected from the group consisting of CTSD, OLFM4, ICAM1.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: May 3, 2022
    Assignee: ProteoMedix AG
    Inventors: Ralph Schiess, Kathrin Endt, Alcibiade Athanasiou, Annalisa Macagno, Thomas Steuber
  • METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS
    Publication number: 20190250163
    Abstract: A method for collecting information about the health status of a subject is proposed involving the quantitative detection, in serum, plasma or blood of the subject, of the concentration of THBS1, the proportion of free PSA (% fPSA), preferably including the concentration of at least one protein selected from the group consisting of CTSD, OLFM4, ICAM1.
    Type: Application
    Filed: July 11, 2017
    Publication date: August 15, 2019
    Applicant: ProteoMedix AG
    Inventors: Ralph SCHIESS, Kathrin ENDT, Alcibiade ATHANASIOU, Annalisa MACAGNO, Thomas STEUBER